Working… Menu

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00442533
Recruitment Status : Completed
First Posted : March 2, 2007
Last Update Posted : April 28, 2017
Excel Diagnostic Imaging Clinics
Radiomedix, Inc.
CHI St. Luke's Health, Texas
Information provided by (Responsible Party):
Ebrahim Delpassand, Radio Isotope Therapy of America

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 30, 2014
Actual Study Completion Date : December 29, 2015